# A Study of LY3532226 in Participants With Obesity

> **NCT06557356** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 132 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** LY3532226
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06557356
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-08-16
- **Primary completion:** 2025-12-12
- **Final completion:** 2025-12-12
- **Target enrollment:** 132 (ACTUAL)
- **Last updated:** 2026-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06557356

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06557356, "A Study of LY3532226 in Participants With Obesity". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06557356. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*